今日申购：海圣医疗

Core Viewpoint - Zhejiang Haisheng Medical Devices Co., Ltd. is set to go public on the Beijing Stock Exchange, aiming to raise approximately 37 million yuan for the upgrade and expansion of its anesthetic and monitoring medical devices, as well as for the establishment of a research and testing center and a marketing service base [2]. Group 1: Company Overview - The company specializes in the research, production, and sales of anesthetic and monitoring medical devices, which are widely used in departments such as anesthesiology, ICU, and emergency [2]. - Huang Haisheng holds a 47.11% stake in the company, making him the controlling shareholder, while his spouse, Wu Xiaoye, indirectly controls an additional 7.81% through Lixin Investment, resulting in a combined control of 54.92% [2]. Group 2: IPO Details - The company plans to issue shares at a price of 12.64 yuan per share, with an expected earnings per share (EPS) ratio of 13.99, aligning with the specialized equipment manufacturing industry [1]. - The total number of shares to be issued is 11.2941 million, with 10.1647 million shares available for online subscription [1]. - The expected total fundraising amount is 142.7577 million yuan, with a net amount of approximately 113.4382 million yuan after deducting estimated issuance costs of 29.3194 million yuan [2].